2020
DOI: 10.1016/j.mehy.2020.110213
|View full text |Cite
|
Sign up to set email alerts
|

SARS-CoV-2-mediated encephalitis: Role of AT2R receptors in the blood-brain barrier

Abstract: At the end of 2019, there was an outbreak of a new Coronavirus 2019 (COVID-19 disease). Studies suggest that SARS-CoV-2 can cause infection in the central nervous system (CNS) and trigger neurological symptoms that include headache, nausea and vomiting, mental confusion and loss of smell or taste. These findings reveal that Coronaviruses have neurological tropism and neuroinvasive capacity. The spread of SARS-CoV-2 in the brain tissue possibly occurs through the systemic circulation as reported in patients aff… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
19
0
3

Year Published

2021
2021
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(23 citation statements)
references
References 44 publications
1
19
0
3
Order By: Relevance
“…Our assumption of apoptosis due to increased percentage of AGTR2+ cells is supported by an earlier study on an intestinal epithelial cell line (Caco-2) where the induction of epithelial cell apoptosis could be triggered by the activation of AGTR2 through GATA-6 and the Bax signaling pathway (27). AGTR2 has also recently been shown to be a potential coreceptor for SARS-CoV-2 entry in various human cells, including those of the central nervous system (98,99). Therefore, an increased expression of AGTR2+ cells in gut tissues during infection may promote increased susceptibility to SARS-CoV-2 infection.…”
Section: Discussionsupporting
confidence: 77%
“…Our assumption of apoptosis due to increased percentage of AGTR2+ cells is supported by an earlier study on an intestinal epithelial cell line (Caco-2) where the induction of epithelial cell apoptosis could be triggered by the activation of AGTR2 through GATA-6 and the Bax signaling pathway (27). AGTR2 has also recently been shown to be a potential coreceptor for SARS-CoV-2 entry in various human cells, including those of the central nervous system (98,99). Therefore, an increased expression of AGTR2+ cells in gut tissues during infection may promote increased susceptibility to SARS-CoV-2 infection.…”
Section: Discussionsupporting
confidence: 77%
“…It is well known that, among other targets, SARS-CoV-2 has a strong neuroinvasive capacity causing multiple neurological symptoms [ 4 ] with increased blood–brain barrier (BBB) damage and neuroinflammation [ 5 ]. There are some indications, however, that not only the SARS-CoV-2 virus but also its S1 spike glycoprotein alone may be responsible for a major part of these problems [ 6 , 7 , 8 , 9 , 10 , 11 , 12 ].…”
Section: Introductionmentioning
confidence: 99%
“…Once attached, the host infection requires the expression of transmembrane serine protease 2 (TMPRSS2) for priming of the spike protein and viral entry into the cell [ 20 22 ]. Along with ACE2 and TMPRSS2, several other molecules have been suggested to participate in SARS-CoV-2 entry into human cells, such as ADAM metallopeptidase domain 17 (ADAM17) [ 23 , 24 ], dipeptidyl peptidase 4 (DPP4) [ 25 , 26 ], angiotensin II receptor type 2 (AGTR2) [ 27 , 28 ], basigin (BSG, also called extracellular matrix metalloproteinase inducer [EMMPRIN] or cluster of differentiation 147 [CD147]) [ 19 , 29 ], aminopeptidase N (ANPEP), [ 30 ], and cathepsin B/L [ 31 , 32 ].…”
Section: Introductionmentioning
confidence: 99%